Familial Atypical Multiple Mole Melanoma SyndromeSymptoms, Doctors, Treatments, Advances & More
Learn About Familial Atypical Multiple Mole Melanoma Syndrome
Pedram Gerami is a Dermatologist practicing medicine in Chicago, Illinois. He has been practicing medicine for over 25 years. Dr. Gerami is rated as an Elite provider by MediFind in the treatment of Familial Atypical Multiple Mole Melanoma Syndrome. He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Melanoma, Familial Atypical Multiple Mole Melanoma Syndrome, Tieche-Jadassohn Nevus, and Giant Congenital Melanocytic Nevus. Dr. Gerami is board certified in American Board Of Dermatology - Dermatology (Certified).
Avera Dermatology — Pierre
Dr. (Joyce) Wesley Fletcher is a dermatologist at Avera Medical Group in Pierre, located in the Helmsley Center at Avera St. Mary's Hospital. Dr. Fletcher is rated as a Distinguished provider by MediFind in the treatment of Familial Atypical Multiple Mole Melanoma Syndrome. She is also highly rated in 35 other conditions, according to our data. Her clinical expertise encompasses Familial Atypical Multiple Mole Melanoma Syndrome, Giant Congenital Melanocytic Nevus, Giant Congenital Nevus, and Neurocutaneous Melanosis.
Phoenixville Valley Forge Dermatology Associates PC
Peter Motel is a Dermatologist and an Internal Medicine provider practicing medicine in Phoenixville, Pennsylvania. Dr. Motel is rated as a Distinguished provider by MediFind in the treatment of Familial Atypical Multiple Mole Melanoma Syndrome. He is also highly rated in 8 other conditions, according to our data. His clinical expertise encompasses Neurocutaneous Melanosis, Familial Atypical Multiple Mole Melanoma Syndrome, Giant Congenital Melanocytic Nevus, and Giant Congenital Nevus. Dr. Motel is board certified in American Board Of Dermatology and American Board Of Internal Medicine.
Summary: This study will investigate how genetic and environmental factors contribute to the development of melanoma, a type of skin cancer, and related conditions. Individuals \>=4 weeks with a personal or family history of melanoma or atypical spitzoid/Spitz tumor may be eligible for this study. Participants will: * Fill out one or two questionnaires about their personal and family medical history. * Pro...
Summary: Johns Hopkins clinical research office quality assurance group will monitor and audit this study at Johns Hopkins. The Sub Investigator at each site will be responsible for internal monitoring at their site.
Published Date: May 10, 2022
Published By: Genetic and Rare Diseases Informnation Center